Αρχική World News ESMO Congress 2021, 16-21 September

ESMO Congress 2021, 16-21 September

LUGANO, Switzerland – The ESMO Congress 2021 will be held as a virtual meeting, on 16-21 September 2021.

The congress programme, with lectures, abstract titles, as well as the accepted late-breaking abstracts, are available in the online programme.

Programme highlights

Among the around 2000 abstracts and late-breaking abstracts that will be presented during the congress days, some of particular scientific relevance are:

  • Results from Phase 3 trials with immunotherapy in:
    • HER2+ metastatic breast cancer (LBA1 – DESTINY-Breast03)
    • Metastatic cervical cancer (LBA2_PR – KEYNOTE-826)
    • Resected high–risk stage II melanoma (LBA3_PR – KEYNOTE-716)
    • KRASG12C-mutated colorectal cancer (LBA6 – KRYSTAL-1)
    • Advanced Gastric/GEJC/Esophageal adenocarcinoma (LBA7 – CheckMate 649)
    • Stage IB-IIIA NSCLC (LBA9)
  • Response to SARS-CoV-2 vaccination in cancer patients (1557O – CAPTURE and LBA8) and impact of COVID-19 sequelae on the treatment pathways and survival of cancer patients who recovered from the infection (1560O_PR)
  • Overall survival in de novo metastatic castration-sensitive prostate cancer (LBA5_PR – PEACE-1) and comparison of two treatment approaches for high-risk non-metastatic prostate cancer (LBA4_PR – STAMPEDE)
  • Advances in the treatment of malignant progressive pheochromocytoma and paraganliomas (567O_PR – FIRSTMAPPP)

ESMO 2021 Opening Press conference

The ESMO 2021 Opening Press Conference will be held via Zoom on Thursday, 9 September, 14:00-14:45 CEST.

Moderator:
  • Antonio Passaro, IEO – Istituto Europeo di Oncologia, Italy – ESMO2021 Press Officer
Panellists:
  • Solange Peters, CHUV – Centre Hospitalier Universitaire Vaudois, Switzerland – ESMO President
  • Pasi Jänne, Dana Farber, USA – ESMO2021 Scientific Co-Chair
  • Alessio Cortellini, University of l’Aquila, Italy – Presenter of abstract 1560O_PR

To participate in the Opening Press Conference, media representatives must be accredited for the congress. Please submit your request for accreditation before Monday 6 September.

Press releases

Press releases will be made available to accredited media representatives a few days ahead of the congress. The PR programme will be available shortly online.

Media Accreditation

ESMO welcomes media interested in reporting from the ESMO events and on cancer issues. The ESMO Press Office will consider only media accreditation requests received through the ESMO Media Registration Form. Accredited journalists will have access to the ESMO official Press Conference (as per timeline above), all congress sessions, e-posters, the virtual exhibition, industry satellite symposia, and will be able to watch the congress webcasts.

Media representatives are required to observe and abide by the ESMO Media Policy, which applies to all ESMO events, and the embargo schedule for the ESMO Congress 2021.

Further information

ESMO Press Office
media@esmo.org

Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Dad Creates Inclusive Children’s Book For Daughter With Disability And Others Like Her

Danny Jordan is a television producer and father of a child with an upper limb difference. Since there aren’t many children’s books out there...

Atlantic rowing trio smash world record and raise thousands for cancer charities

Abby, Charlotte and Kat (left to right) in English Harbour after breaking the world record. Three British women, including one with an incurable cancer, have...

Artificial Intelligence for Diagnosis and Gleason Grading of Prostate Cancer

A global artificial intelligence (AI) competition, the Prostate cANcer graDe Assessment (PANDA) challenge, compiled and publicly released a European cohort for AI development, the...

Daughter And Her Terminally Ill Dad Go On Bucket List Adventures In His Final Days

72-year-old Patrick Mitchell loves life and always wanted to live past 100, but everything changed when he found out that he had terminal stage...

A new year of expanding research horizons

As a new year of research gets underway, we ask two of our Research Committee Chairs to take stock of the incredible science done...

Young Women At Increased Risk Of Aggressive Breast Cancer

Breast cancer is on the rise among younger women. According to a study published in the Journal of the American Medical Association, there has been...